Prochlorperazine 20 mg/0.5 mL Topical Gel is a semisolid formulation designed for easy and precise application on the skin through a convenient pump mechanism. This gel-like consistency ensures targeted treatment and effective absorption of the active ingredient.
This formulation is primarily used to treat nausea, vomiting, and vertigo associated with various conditions, including migraines and vestibular disorders. By delivering prochlorperazine directly through the skin, it offers a non-invasive alternative for patients seeking relief from these symptoms.

Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Prochlorperazine 20 mg/0.5 mL Topical Gel is a semisolid formulation designed for easy and precise application on the skin. Dispensed through a pump mechanism, this gel allows for targeted treatment and absorption of the active ingredient directly through the skin in a gel-like consistency.
Prochlorperazine is a phenothiazine derivative that is commonly used for its antiemetic and antipsychotic properties. It is primarily indicated for the control of severe nausea and vomiting, and it may also be used in the management of schizophrenia and anxiety disorders. By inhibiting dopamine receptors in the brain, prochlorperazine helps alleviate symptoms associated with these conditions.
The topical gel formulation offers several advantages over traditional oral or injectable routes of administration. For patients who experience difficulty swallowing pills or are prone to vomiting, transdermal delivery ensures that the medication is absorbed without causing further gastrointestinal discomfort. Additionally, the topical application can minimize systemic side effects often associated with oral administration, such as drowsiness or dizziness.
For patients, this formulation provides a convenient and non-invasive method of medication delivery. The pump mechanism facilitates accurate dosing, reducing the risk of overdose or underdose. The gel is applied directly to the skin, where it is absorbed into the bloodstream, allowing for steady and controlled release of the medication. This can lead to improved symptom management and overall treatment efficacy.
Prescribers may find this formulation beneficial for patients who require an alternative to oral medications due to gastrointestinal issues or for those who prefer not to take pills. The topical gel allows for flexible dosing and can be tailored to meet individual patient needs. It also provides an option for patients who may have adherence challenges with traditional dosage forms.
It is important for both patients and prescribers to consider potential side effects and interactions. While topical administration can reduce some systemic side effects, patients should be monitored for local skin reactions, such as redness or irritation at the application site. Prescribers should assess the patient's overall medication regimen to avoid potential drug interactions and contraindications.
If you have any questions about Prochlorperazine 20 mg/0.5 mL Topical Gel or how it may be beneficial in treatment, please reach out to us.
Prochlorperazine 20 mg/0.5 mL Topical Gel is a semisolid formulation designed for easy and precise application on the skin, allowing for targeted treatment or absorption of active ingredients. This formulation is primarily used to manage symptoms associated with nausea, vomiting, and vertigo, and may also be used in the treatment of certain psychiatric disorders such as schizophrenia and anxiety. As with any medication, it is crucial to be aware of potential drug interactions that could affect the efficacy and safety of the treatment.
Prochlorperazine is a phenothiazine derivative, and its use in topical form may still interact with other medications, despite its localized application. Patients and prescribers should be aware that prochlorperazine can potentiate the effects of other central nervous system (CNS) depressants, including alcohol, sedatives, hypnotics, and narcotics. This can lead to increased sedation and respiratory depression, which may be dangerous. Therefore, concurrent use of these substances should be approached with caution, and dosages may need to be adjusted accordingly.
Additionally, prochlorperazine may interact with antihypertensive medications, potentially enhancing their hypotensive effects. Patients using antihypertensive drugs should be monitored for signs of excessive blood pressure reduction, such as dizziness or fainting, and adjustments to their medication regimen may be necessary. Furthermore, prochlorperazine can affect the action of anticholinergic drugs, leading to increased anticholinergic side effects such as dry mouth, constipation, and urinary retention.
Patients taking anticoagulants should also exercise caution, as prochlorperazine may alter the effects of these medications, potentially increasing the risk of bleeding. Regular monitoring of coagulation parameters is advised when these drugs are used concurrently. Moreover, prochlorperazine may interact with medications that prolong the QT interval, such as certain antiarrhythmics, increasing the risk of cardiac arrhythmias. Patients with a history of cardiac issues should be closely monitored, and alternative treatments should be considered if necessary.
It is important to note that prochlorperazine may also interact with other medications metabolized by the liver enzyme CYP2D6. This can lead to altered plasma levels of either prochlorperazine or the co-administered drug, necessitating dosage adjustments. Patients should inform their healthcare provider of all medications they are currently taking, including over-the-counter drugs and supplements, to ensure safe and appropriate use of prochlorperazine topical gel.
If you have any questions or concerns about potential drug interactions with Prochlorperazine 20 mg/0.5 mL Topical Gel, please reach out to us at Bayview Pharmacy. Our team of knowledgeable compounding pharmacists is here to assist you in ensuring the safe and appropriate use of this medication.
Prochlorperazine 20 mg/0.5 mL Topical Gel is a specialized formulation designed to deliver the active ingredient, prochlorperazine, directly through the skin. This semisolid gel is dispensed via a pump mechanism, allowing for easy and precise application. The gel-like consistency ensures that the medication is evenly distributed over the targeted area, facilitating optimal absorption through the skin layers. This method of delivery is particularly beneficial for patients who may have difficulty swallowing oral medications or for those who require localized treatment.
Prochlorperazine is a medication primarily used to manage nausea and vomiting, as well as to treat certain psychiatric disorders such as schizophrenia. It functions as a dopamine receptor antagonist, which means it blocks dopamine receptors in the brain. By inhibiting these receptors, prochlorperazine helps to correct the chemical imbalances that can lead to nausea, vomiting, and certain psychiatric symptoms. When applied topically, the gel allows for the medication to be absorbed into the bloodstream through the skin, providing systemic effects without the need for oral administration.
The topical application of prochlorperazine offers several advantages. It bypasses the gastrointestinal tract, reducing the risk of gastrointestinal side effects and potential drug interactions that can occur with oral medications. Additionally, the controlled release of the medication through the skin can provide a more consistent therapeutic effect, which is particularly useful in managing chronic conditions. The pump mechanism ensures that each dose is accurately measured, promoting adherence to prescribed treatment regimens and minimizing the risk of over- or under-dosing.
For patients and prescribers considering this formulation, it is important to understand the proper application technique to maximize the benefits of the treatment. The gel should be applied to clean, dry skin, and it is advisable to avoid areas with cuts or abrasions to prevent irritation. Patients should follow the dosing instructions provided by their healthcare provider and report any adverse reactions or concerns promptly. As with any medication, it is crucial to discuss any other medications or health conditions with a healthcare provider to ensure the safe and appropriate use of prochlorperazine topical gel.
If you have any questions or need further information about Prochlorperazine 20 mg/0.5 mL Topical Gel, please do not hesitate to reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to assist you with any inquiries or concerns you may have regarding this formulation or its use in treating specific disease states.
Prochlorperazine 20 mg/0.5 mL Topical Gel is used for targeted treatment or absorption of active ingredients through the skin, often for conditions like nausea, vertigo, or other symptoms that require localized treatment.
Apply the gel directly to the skin using the pump mechanism for precise dosing. Ensure the area is clean and dry before application, and follow your healthcare provider's instructions regarding the amount and frequency of use.
No, you should not apply Prochlorperazine Topical Gel to broken or irritated skin. It is intended for use on intact skin only.
The pump mechanism dispenses a precise amount of gel with each press, ensuring consistent dosing and easy application without the need for measuring.
Some users may experience skin irritation, redness, or itching at the application site. If you experience severe side effects or an allergic reaction, discontinue use and consult your healthcare provider.
Before using Prochlorperazine Topical Gel with other medications, consult your healthcare provider to avoid potential interactions or side effects.
Store the gel at room temperature, away from direct sunlight and moisture. Keep it out of reach of children and pets.
The suitability of Prochlorperazine Topical Gel for children should be determined by a healthcare provider. It is important to follow their guidance regarding pediatric use.
If you miss a dose, apply it as soon as you remember. If it is almost time for your next dose, skip the missed dose and resume your regular schedule. Do not double the dose to catch up.
If you are pregnant or breastfeeding, consult your healthcare provider before using Prochlorperazine Topical Gel to ensure it is safe for you and your baby.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)